Original Article

You have full text access to this OnlineOpen article

The development of interval breast malignancies in patients with BRCA mutations

  1. Ian K. Komenaka M.D.†,*,
  2. Beth-Ann Ditkoff M.D.,
  3. Kathie-Ann Joseph M.D., M.P.H.,
  4. Donna Russo M.S.,
  5. Prakash Gorroochurn Ph.D.,
  6. Marie Ward M.D.,
  7. Elizabeth Horowitz R.-P.A.C.,
  8. Mahmoud B. El-Tamer M.D.,
  9. Freya R. Schnabel M.D.

Article first published online: 12 APR 2004

DOI: 10.1002/cncr.20221

Issue

Cancer

Cancer

Volume 100, Issue 10, pages 2079–2083, 15 May 2004

Additional Information

How to Cite

Komenaka, I. K., Ditkoff, B.-A., Joseph, K.-A., Russo, D., Gorroochurn, P., Ward, M., Horowitz, E., El-Tamer, M. B. and Schnabel, F. R. (2004), The development of interval breast malignancies in patients with BRCA mutations. Cancer, 100: 2079–2083. doi: 10.1002/cncr.20221

Author Information

  1. The Comprehensive Breast Center, Columbia-Presbyterian Medical Center, New York, New York

  1. †

    Fax: (212) 305-1060

*c/o Beth-Ann Ditkoff, M.D., Columbia-Presbyterian Medical Center, Atchley Pavilion, 10th Floor, 161 Fort Washington Avenue, New York, NY 10032

Publication History

  1. Issue published online: 29 APR 2004
  2. Article first published online: 12 APR 2004
  3. Manuscript Accepted: 24 FEB 2004
  4. Manuscript Revised: 2 FEB 2004
  5. Manuscript Received: 27 OCT 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (72K)

REFERENCES

  • 1
    Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003; 53: 5–26.
    Direct Link:
  • 2
    Dodd GD. American Cancer Society guidelines on screening for breast cancer. An overview. Cancer. 1992; 69(7 Suppl ): 1885–1887.
    Direct Link:
  • 3
    U.S. Preventive Services Task Force. Guide to clinical preventive services. Washington, DC: U.S. Department of Health and Human Services, 1989.
  • 4
    Mettlin C, Smart CR. Breast cancer detection guidelines for women aged 40 to 49 years: rationale for the American Cancer Society reaffirmation of recommendations. American Cancer Society. CA Cancer J Clin. 1994; 44: 248–255.
    Direct Link:
  • 5
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993; 85: 1644–1656.
  • 6
    Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001; 345: 159–164.
  • 7
    American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003; 21: 2397–2406.
  • 8
    Robson ME. Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. Cancer Control. 2002; 9: 457–465.
  • 9
    Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997; 277: 997–1003.
  • 10
    Eisinger F, Alby N, Bremond A, et al. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. Ann Oncol. 1998; 9: 939–950.
  • 11
    Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002; 20: 1260–1268.
  • 12
    FlemingID, CooperJS, HensonDE, HutterRV, KennedyBJ, MurphyGP, editors. American Joint Committee on Cancer staging manual (5th edition). Philadelphia: JB Lippincott, 1997.
  • 13
    Cady B. Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer. 1997; 79: 1856–1861; discussion, 1862–1864.
    Direct Link:
  • 14
    Heimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer. 1998; 82: 2221–2226.
    Direct Link:
  • 15
    Leconte I, Feger C, Galant C, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol. 2003; 180: 1675–1679.
  • 16
    Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002; 225: 165–175.
  • 17
    Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998; 209: 511–518.
  • 18
    Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in young women. J Clin Oncol. 1998; 16: 1642–1649.
  • 19
    Karp SE, Tonin PN, Begin LR, et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer. 1997; 80: 435–441.
    Direct Link:
  • 20
    Armes JE, Egan AJ, Southey MC, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer. 1998; 83: 2335–2345.
    Direct Link:
View Full Article (HTML) Get PDF (72K)